[144] Artivion, Inc. SEC Filing
Artivion, Inc. (AORT) filed a Form 144 reporting a proposed sale of common stock. The filing shows 10,802 shares intended for sale on 08/12/2025 through Morgan Stanley Smith Barney LLC on the NYSE with an aggregate market value of $471,752.51. The issuer's outstanding shares are listed as 47,183,658.
The securities were acquired on 08/12/2025 through a stock option exercise from the issuer and paid in cash. The filer reports "Nothing to Report" for securities sold during the past three months. The notice includes the standard representation that the seller does not possess undisclosed material adverse information about the issuer.
Artivion, Inc. (AORT) ha presentato un Form 144 che segnala una proposta di vendita di azioni ordinarie. Il documento indica 10,802 azioni destinate alla vendita il 08/12/2025 tramite Morgan Stanley Smith Barney LLC sul NYSE con un valore di mercato aggregato di $471,752.51. Le azioni in circolazione dell'emittente sono riportate come 47,183,658.
I titoli sono stati acquistati il 08/12/2025 tramite un esercizio di stock option dall'emittente e pagati in contanti. Il dichiarante segnala "Niente da segnalare" per titoli venduti negli ultimi tre mesi. L'avviso include la rappresentazione standard che il venditore non 猫 in possesso di informazioni negative materiali non divulgate sull'emittente.
Artivion, Inc. (AORT) present贸 un Form 144 informando una propuesta de venta de acciones ordinarias. La presentaci贸n muestra 10,802 acciones previstas para su venta el 08/12/2025 a trav茅s de Morgan Stanley Smith Barney LLC en la NYSE con un valor de mercado agregado de $471,752.51. Las acciones en circulaci贸n del emisor se indican como 47,183,658.
Los valores fueron adquiridos el 08/12/2025 mediante un ejercicio de stock options del emisor y pagados en efectivo. El declarante informa "Nada que informar" por valores vendidos en los 煤ltimos tres meses. El aviso incluye la declaraci贸n est谩ndar de que el vendedor no posee informaci贸n material adversa no divulgada sobre el emisor.
Artivion, Inc. (AORT)鞚� 鞝滌晥霅� 氤错喌欤� 毵り皝鞚� 氤搓碃頃� Form 144毳� 鞝滌稖頄堨姷雼堧嫟. 鞝涤稖靹涤棎电� 10,802欤缄皜 08/12/2025鞐� Morgan Stanley Smith Barney LLC毳� 韱淀暣 NYSE鞐愳劀 毵り皝霅� 鞓堨爼鞚措┌ 齑� 鞁滉皜臧� $471,752.51搿� 響滌嫓霅橃柎 鞛堨姷雼堧嫟. 氚滍枆須岇偓鞚� 鞙犿喌 欤检嫕靾橂姅 47,183,658欤茧 旮办灛霅橃柎 鞛堨姷雼堧嫟.
頃措嫻 歃濌秾鞚� 氚滍枆須岇偓搿滊秬韯办潣 鞀ろ啞鞓奠厴 頄夓偓毳� 韱淀暣 08/12/2025鞐� 旆摑霅橃棃鞙茧┌ 顺勱笀鞙茧 歆�旮夒悩鞐堨姷雼堧嫟. 鞁犼碃鞚胳潃 歆�雮� 3臧滌洈 霃欖晥 毵り皝霅� 歃濌秾鞐� 雽�頃� "氤搓碃頃� 靷暛 鞐嗢潓"鞚措澕瓿� 氤搓碃頄堨姷雼堧嫟. 韱奠靹滌棎電� 毵る弰鞚胳澊 氚滍枆須岇偓鞐� 甏�頃� 氙戈车臧� 欷戨寑頃� 攵堧Μ頃� 鞝曤炒毳� 氤挫湢頃橁碃 鞛堨 鞎婋嫟電� 響滌 歆勳垹鞚� 韽暔霅橃柎 鞛堨姷雼堧嫟.
Artivion, Inc. (AORT) a d茅pos茅 un Form 144 signalant une proposition de vente d'actions ordinaires. Le d茅p么t indique 10,802 actions destin茅es 脿 la vente le 08/12/2025 par l'interm茅diaire de Morgan Stanley Smith Barney LLC sur le NYSE pour une valeur de march茅 globale de $471,752.51. Le nombre d'actions en circulation de l'茅metteur est indiqu茅 comme 47,183,658.
Les titres ont 茅t茅 acquis le 08/12/2025 par exercice d'options sur actions aupr猫s de l'茅metteur et r茅gl茅s en 别蝉辫猫肠别蝉. Le d茅clarant indique "Rien 脿 d茅clarer" pour les titres vendus au cours des trois derniers mois. L'avis comprend la d茅claration standard selon laquelle le vendeur ne d茅tient pas d'informations d茅favorables importantes non divulgu茅es concernant l'茅metteur.
Artivion, Inc. (AORT) hat ein Form 144 eingereicht, in dem ein geplanter Verkauf von Stammaktien gemeldet wird. Die Einreichung weist 10,802 zum Verkauf vorgesehene Aktien am 08/12/2025 眉产别谤 Morgan Stanley Smith Barney LLC an der NYSE mit einem aggregierten Marktwert von $471,752.51 aus. Die ausstehenden Aktien des Emittenten sind mit 47,183,658 angegeben.
Die Wertpapiere wurden am 08/12/2025 durch Aus眉bung einer Aktienoption vom Emittenten erworben und in Bargeld bezahlt. Der Einreicher meldet "Nichts zu melden" f眉r in den letzten drei Monaten ver盲u脽erte Wertpapiere. Die Mitteilung enth盲lt die 眉bliche Zusicherung, dass der Verk盲ufer keine nicht offengelegten wesentlichen nachteiligen Informationen 眉产别谤 den Emittenten besitzt.
- None.
- None.
Insights
TL;DR: A routine Form 144 for 10,802 shares valued at $471,752; size and disclosure suggest limited investor impact.
The filing documents a proposed sale of 10,802 common shares on 08/12/2025 via Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $471,752.51 and 47,183,658 shares outstanding. The shares were acquired the same day by stock option exercise and paid in cash. No prior sales are reported for the past three months. From a trading-impact perspective, the transaction is modest relative to typical market volumes and the filing meets Rule 144 disclosure conventions.
TL;DR: Documentation aligns with Rule 144 mechanics; includes seller's certification on material nonpublic information.
The Form 144 lists the broker, class of security, acquisition method (stock option exercise), payment type (cash), and that there were no sales in the preceding three months. The filing also contains the signature representation that the seller does not possess undisclosed material adverse information. These elements indicate procedural compliance with Rule 144 disclosure requirements; there is no evidence in the filing of aggregated sales or additional beneficiaries requiring disclosure.
Artivion, Inc. (AORT) ha presentato un Form 144 che segnala una proposta di vendita di azioni ordinarie. Il documento indica 10,802 azioni destinate alla vendita il 08/12/2025 tramite Morgan Stanley Smith Barney LLC sul NYSE con un valore di mercato aggregato di $471,752.51. Le azioni in circolazione dell'emittente sono riportate come 47,183,658.
I titoli sono stati acquistati il 08/12/2025 tramite un esercizio di stock option dall'emittente e pagati in contanti. Il dichiarante segnala "Niente da segnalare" per titoli venduti negli ultimi tre mesi. L'avviso include la rappresentazione standard che il venditore non 猫 in possesso di informazioni negative materiali non divulgate sull'emittente.
Artivion, Inc. (AORT) present贸 un Form 144 informando una propuesta de venta de acciones ordinarias. La presentaci贸n muestra 10,802 acciones previstas para su venta el 08/12/2025 a trav茅s de Morgan Stanley Smith Barney LLC en la NYSE con un valor de mercado agregado de $471,752.51. Las acciones en circulaci贸n del emisor se indican como 47,183,658.
Los valores fueron adquiridos el 08/12/2025 mediante un ejercicio de stock options del emisor y pagados en efectivo. El declarante informa "Nada que informar" por valores vendidos en los 煤ltimos tres meses. El aviso incluye la declaraci贸n est谩ndar de que el vendedor no posee informaci贸n material adversa no divulgada sobre el emisor.
Artivion, Inc. (AORT)鞚� 鞝滌晥霅� 氤错喌欤� 毵り皝鞚� 氤搓碃頃� Form 144毳� 鞝滌稖頄堨姷雼堧嫟. 鞝涤稖靹涤棎电� 10,802欤缄皜 08/12/2025鞐� Morgan Stanley Smith Barney LLC毳� 韱淀暣 NYSE鞐愳劀 毵り皝霅� 鞓堨爼鞚措┌ 齑� 鞁滉皜臧� $471,752.51搿� 響滌嫓霅橃柎 鞛堨姷雼堧嫟. 氚滍枆須岇偓鞚� 鞙犿喌 欤检嫕靾橂姅 47,183,658欤茧 旮办灛霅橃柎 鞛堨姷雼堧嫟.
頃措嫻 歃濌秾鞚� 氚滍枆須岇偓搿滊秬韯办潣 鞀ろ啞鞓奠厴 頄夓偓毳� 韱淀暣 08/12/2025鞐� 旆摑霅橃棃鞙茧┌ 顺勱笀鞙茧 歆�旮夒悩鞐堨姷雼堧嫟. 鞁犼碃鞚胳潃 歆�雮� 3臧滌洈 霃欖晥 毵り皝霅� 歃濌秾鞐� 雽�頃� "氤搓碃頃� 靷暛 鞐嗢潓"鞚措澕瓿� 氤搓碃頄堨姷雼堧嫟. 韱奠靹滌棎電� 毵る弰鞚胳澊 氚滍枆須岇偓鞐� 甏�頃� 氙戈车臧� 欷戨寑頃� 攵堧Μ頃� 鞝曤炒毳� 氤挫湢頃橁碃 鞛堨 鞎婋嫟電� 響滌 歆勳垹鞚� 韽暔霅橃柎 鞛堨姷雼堧嫟.
Artivion, Inc. (AORT) a d茅pos茅 un Form 144 signalant une proposition de vente d'actions ordinaires. Le d茅p么t indique 10,802 actions destin茅es 脿 la vente le 08/12/2025 par l'interm茅diaire de Morgan Stanley Smith Barney LLC sur le NYSE pour une valeur de march茅 globale de $471,752.51. Le nombre d'actions en circulation de l'茅metteur est indiqu茅 comme 47,183,658.
Les titres ont 茅t茅 acquis le 08/12/2025 par exercice d'options sur actions aupr猫s de l'茅metteur et r茅gl茅s en 别蝉辫猫肠别蝉. Le d茅clarant indique "Rien 脿 d茅clarer" pour les titres vendus au cours des trois derniers mois. L'avis comprend la d茅claration standard selon laquelle le vendeur ne d茅tient pas d'informations d茅favorables importantes non divulgu茅es concernant l'茅metteur.
Artivion, Inc. (AORT) hat ein Form 144 eingereicht, in dem ein geplanter Verkauf von Stammaktien gemeldet wird. Die Einreichung weist 10,802 zum Verkauf vorgesehene Aktien am 08/12/2025 眉产别谤 Morgan Stanley Smith Barney LLC an der NYSE mit einem aggregierten Marktwert von $471,752.51 aus. Die ausstehenden Aktien des Emittenten sind mit 47,183,658 angegeben.
Die Wertpapiere wurden am 08/12/2025 durch Aus眉bung einer Aktienoption vom Emittenten erworben und in Bargeld bezahlt. Der Einreicher meldet "Nichts zu melden" f眉r in den letzten drei Monaten ver盲u脽erte Wertpapiere. Die Mitteilung enth盲lt die 眉bliche Zusicherung, dass der Verk盲ufer keine nicht offengelegten wesentlichen nachteiligen Informationen 眉产别谤 den Emittenten besitzt.
FAQ
How many Artivion (AORT) shares are reported for proposed sale in this Form 144?
What is the aggregate market value of the shares in the AORT Form 144?
When were the AORT shares acquired and by what method?
Through which broker and exchange will the AORT shares be sold?
Does the filing report any securities sold in the past three months for the seller?
How were the shares paid for according to the filing?
